Addex TherapeuticsADXN
13F holders, Q4 2024 (December 31)5holders +2
2new positions
1sold out
1famous investor
$7.00avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Addex Therapeutics Ltd. (ADXN) in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($85K), Morgan Stanley ($13K) and GAMMA Investing LLC ($7K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Addex Therapeutics Ltd.
- CUSIP
- 00654J206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $92K |
| Exits | 1 | $10K |
All 13F filers, Q3 2024 → Q4 2024: 14,709 shares bought and 1,000 shares sold, net +13,709 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Citadel Advisors | 0.00% | New | 12,079 | $85K |
| Morgan Stanley | 0.00% | Add +438.2% | 1,900 | $13K |
| GAMMA Investing LLC | 0.00% | New | 1,011 | $7K |
| Rhumbline Advisers | 0.00% | Add +205.7% | 107 | $749 |
| SBI Securities Co., Ltd. | 0.00% | — | 5 | $35 |
"% of holder's portfolio" is ADXN's weight in each manager's 13F, not the share of Addex Therapeutics Ltd. the manager owns.